Pacific ASC will be built at the Shops at Dole Cannery. Cellular Bioengineering is developing a line of artificial corneas that the company hopes to have government clearance for implanting by the end of next year, according to the report.
Officials from Cellular Bioengineering did not release any further details about Pacific ASC.
Read the Business Journal’s report about Pacific ASC.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
